Jynarque
Ended Awarded Last action
- Contract number
- 36C24622N0564
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $11,414
Award facts
- Contract value 100% obligated
- $11,413.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6850 Miscellaneous Chemical Specialties
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 6 (VISN 6), awarded a delivery order to Otsuka America Pharmaceutical Inc. on March 21, 2022, for the supply of Jynarque (tolvaptan), a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. This firm fixed-price delivery order carries a ceiling value of $11,413.72 and is scheduled for completion by April 1, 2022, with performance occurring in Pittsburgh, Pennsylvania. The award was issued without any small business set-aside designation, reflecting Otsuka America Pharmaceutical Inc.'s status as a large pharmaceutical manufacturer.
This delivery order falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is issued against Otsuka America Pharmaceutical Inc.'s larger Blanket Purchase Agreement with the VA's National Acquisition Center, valued at approximately $83.3 million and extending through March 2026. The BPA enables VA facilities across multiple Integrated Service Networks to procure Jynarque efficiently, supporting the VA's mission to provide specialized pharmaceutical treatments to veterans nationwide. Otsuka America Pharmaceutical Inc., headquartered in Rockville, Maryland, has established itself as a key supplier of complex pharmaceutical products to the VA's Veterans Health Administration through consistent delivery order awards across multiple regional service networks.
Quick answers
Who was awarded contract 36C24622N0564?
36C24622N0564 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on March 21, 2022.
How much is contract 36C24622N0564 worth?
The government has obligated $11,414 on 36C24622N0564.
Is contract 36C24622N0564 an order under another contract?
Yes. 36C24622N0564 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24622N0564 competed?
The extent of competition for 36C24622N0564 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award